Loading clinical trials...
Loading clinical trials...
A Phase II Randomized Controlled Trial of Stereotactic Ablative Body Radiotherapy (SAbR) With or Without Neurovascular Sparing for Erectile Function Preservation in Localized Prostate Cancer
Conditions
Interventions
30Gy (Gray) planning target volume (PTV)
Locations
8
United States
UCSF ( Department of Radiation Oncology University of California San Francisco)
San Francisco, California, United States
University of Colorado Hospital
Aurora, Colorado, United States
Penrose Hospital
Colorado Springs, Colorado, United States
University of Michigan- Michigan Medicine
Ann Arbor, Michigan, United States
Stony Brook University Cancer Center
Stony Brook, New York, United States
Cleveland Clinic
Cleveland, Ohio, United States
Start Date
April 24, 2018
Primary Completion Date
April 1, 2027
Completion Date
April 1, 2029
Last Updated
June 4, 2025
Lead Sponsor
University of Texas Southwestern Medical Center
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions